ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 20 of 156 for:    pituitary tumor

Genome-wide Association Study of Pituitary Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01442220
Recruitment Status : Unknown
Verified September 2011 by Zhaoyun Zhang, Huashan Hospital.
Recruitment status was:  Recruiting
First Posted : September 28, 2011
Last Update Posted : September 28, 2011
Sponsor:
Information provided by (Responsible Party):
Zhaoyun Zhang, Huashan Hospital

Brief Summary:
Pituitary adenomas is a very common disease, but the cause and genetics hasn't been identified. The investigators are going to use genome-wide association study to identify genes that may be related to pituitary adenomas.

Condition or disease
Pituitary Adenomas

Study Type : Observational
Estimated Enrollment : 12500 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Genome-wide Association Study of Pituitary Tumors
Study Start Date : September 2011
Estimated Primary Completion Date : June 2013
Estimated Study Completion Date : July 2014

Resource links provided by the National Library of Medicine





Biospecimen Retention:   Samples With DNA
DNA samples


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients diagnosed with pituitary adenomas and healthy controls will be included.
Criteria

Inclusion Criteria:

  • patients diagnosed with pituitary adenomas

Exclusion Criteria:

  • patients with a family history of endocrine tumors

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01442220


Contacts
Contact: Yao Zhang, Dr. 86-13916872553 zhaoyaohs@vip.sina.com

Locations
China, Shanghai
Huashan Hospital Recruiting
Shanghai, Shanghai, China, 200040
Contact: Yao Zhao    86-13916872553    zhaoyaohs@vip.sina.com   
Principal Investigator: Yao Zhao         
Sponsors and Collaborators
Huashan Hospital
Investigators
Principal Investigator: Yao Zhao, M.D. Huashan Hospital

Responsible Party: Zhaoyun Zhang, Doctor, Huashan Hospital
ClinicalTrials.gov Identifier: NCT01442220     History of Changes
Other Study ID Numbers: KY2011-277
First Posted: September 28, 2011    Key Record Dates
Last Update Posted: September 28, 2011
Last Verified: September 2011

Additional relevant MeSH terms:
Pituitary Diseases
Pituitary Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Hypothalamic Neoplasms
Supratentorial Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Adenoma
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases